(Q39341248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Combating the drug resistance of cisplatin using a platinum prodrug based delivery system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Chengqiong Mao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Guolin Ma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Yuanzeng Min

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Siming Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Yangzhong Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

25 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

Angewandte Chemie International Edition

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

6742-6747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639083%20AND%20SRC:MED&resulttype=core&format=json

Activating platinum anticancer complexes with visible light.

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Drug transporters of platinum-based anticancer agents and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

The resurgence of platinum-based cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Interaction between platinum complexes and a methionine motif found in copper transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Basis for design and development of platinum(IV) anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Trans-platinum complexes in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Monodisperse magnetic nanoparticles for theranostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Nanoscale metal-organic frameworks for biomedical imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Gold nanorods for platinum based prodrug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

The mechanism of action of platinum anticancer agents--what do we really know about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Studies on cellular accumulation of satraplatin and its major metabolite JM118 and their interactions with glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

The status of platinum anticancer drugs in the clinic and in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Recent progress in tumor pH targeting nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562

Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201201562